Opendata, web and dolomites

SKIN SUBSTITUTE SIGNED

Development of hybrid artificial skin substitute for chronic diabetic wounds

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SKIN SUBSTITUTE project word cloud

Explore the words cloud of the SKIN SUBSTITUTE project. It provides you a very rough idea of what is the project "SKIN SUBSTITUTE" about.

pandit    trial    translate    foot    collaborative    healing    skin    international    maturity    approved    ago    strategies    rabbit    3d    molecular    diabetes    histological    incidence    techniques    stereological    standards    property    position    vivo    alloxan    garcia    regulatory    network    antimicrobial    mortality    leadership    requiring    skills    hmsc    keratinocyte    substitute    integra    career    models    me    15    communication    antibacterial    24    therapeutic    compatibility    reimbursement    prof    first    affairs    independence    dulce    2030    wound    agents    fda    hybrid    alloderm    professional    progress    14    diabetic    efficacy    group    transferable    it    goals    diversity    worse    clinical    combines    polymer    papy    evaluation    68    completion    discipline    fibroblast    time    innovative    grafts    synthetic    exchequer    biology    device    malignancies    cell    nanoparticles    vitro    validate    leveraging    43    motivation    secondment    patients    controls    acting    components    reg    amputation    biopolymer    plan    strategy    setting    complementary    bioactive    ulcer    medical    cellular    gold    establishing    scaffold    million    people    dfu    training    interventions    incorporating    culture    clinic    functionalized    benefit    model    intellectual    commercial    zno   

Project "SKIN SUBSTITUTE" data sheet

The following table provides information about the project.

Coordinator
NATIONAL UNIVERSITY OF IRELAND GALWAY 

Organization address
address: UNIVERSITY ROAD
city: Galway
postcode: H91
website: www.nuigalway.ie

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 187˙866 €
 EC max contribution 187˙866 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NATIONAL UNIVERSITY OF IRELAND GALWAY IE (Galway) coordinator 187˙866.00

Map

 Project objective

It is estimated that the incidence of diabetes in Europe will affect 43 million people by 2030. 15% of diabetic patients develop a diabetic foot ulcer (DFU) with 14-24% of these patients requiring amputation. Mortality following amputation of 50–68% is comparable or worse than for most malignancies. My strategy will develop for the first time a skin substitute which combines a biopolymer and a functionalized synthetic FDA approved polymer incorporating bioactive components and AgO and ZnO nanoparticles as antibacterial agents. The cellular compatibility of the hybrid skin substitute will be assessed on fibroblast, keratinocyte and hMSC in a 3D cell culture model. The antimicrobial efficacy will be assessed in vitro and in vivo. The optimised scaffold will be assessed in an alloxan-induced diabetic rabbit ulcer model with gold standards Integra® and Alloderm® skin grafts acting as commercial controls to validate the commercial potential of the technology. Progress to completion will be reviewed by a Research and Professional Development Plan which will provide both discipline-specific and complementary technical training (molecular biology, diabetic wound healing in vivo models, and histological and stereological techniques) and generic and complementary transferable skills training (e.g. intellectual property, leadership skills, motivation skills, communication skills, leveraging non-exchequer funding, regulatory affairs, clinical trial design, reimbursement strategies, medical device evaluation and regulatory affairs). I will benefit from Prof Pandit’s and Prof Dulce Papy-Garcia (secondment) international collaborative network in the field of diabetic wound healing. This training will facilitate me to achieve my future career goals of achieving a position of professional maturity, diversity and independence by establishing my own research group at a leading European institution and enabling me to translate innovative therapeutic interventions to the clinic setting.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKIN SUBSTITUTE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SKIN SUBSTITUTE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

distalC-Hfun (2020)

Transient directing group for catalytic distal C–H functionalisation

Read More  

NEUTON (2019)

NEUTrino OscillatioN analysis at T2K and SuperKamiokande experiments: Can neutrinos explain the matter-antimatter asymmetry in the Universe?

Read More  

TRACE-AD (2019)

Tracking the Effects of Amyloid and Tau Pathology on Brain Systems and Cognition in Early Alzheimer’s Disease

Read More